Annis Gardner Whiting Capital Advisors, LLC Astrazeneca PLC Transaction History

Annis Gardner Whiting Capital Advisors, LLC

$485 Billion
Q3 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 11, 2025	BUY	$64.87 - $75.0 $31,786 - $36,750	490 New	490 $34.2 Million
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $34,176 - $38,959	560 New	560 $37.9 Million

Others Institutions Holding AZN

# of Institutions

1,554

Shares Held

503M

Call Options Held

5.54M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.

Account